Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Fluidigm; Gen-Probe; Arrayit; LGC Genomics; ACMG Foundation for Genetic and Genomic Medicine

NEW YORK (GenomeWeb News) – Fluidigm this week said that it has formed a wholly owned subsidiary in China and has begun direct service to customers in that country. The subsidiary is called Fluidigm (Shanghai) Instrument Technology.

According to a recent survey conducted by investment bank Jeffries, US molecular diagnostics labs expressed "stronger than expected" interest in Gen-Probe's recently launched assays for trichomonas and human papillomavirus, as well as "notable enthusiasm" for the upcoming launch of the company's Panther molecular diagnostics system. As GenomeWeb Daily News sister publication PCR Insider reported this week, Jeffries believes Gen-Probe's installed base for Panther systems "could exceed 300 instruments by the end of 2013.

Arrayit said this week that it had fourth-quarter 2011 sales of nearly $1.3 million, up 34 percent from sales of $930,000 for Q4 2010. Its full-year 2011 sales increased 24 percent to $3.8 million from $3.1 million.

LGC Genomics has launched its new US genomics services lab in Beverly, Mass. The London-based firm provides services including genotyping, DNA extraction, and Sanger and next-generation sequencing.

The American College of Medical Genetics Foundation has changed its name to the ACMG Foundation for Genetic and Genomic Medicine. The foundation is a non-profit focused on supporting education, research, and the safe and effective practice of genetic and genomic medicine.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.